Mukka proteins Limited's board of directors has approved a strategic acquisition that will consolidate its control over subsidiary Haris Marine Products Private Limited. The board meeting held on February 12, 2026, sanctioned the purchase of additional equity shares to achieve complete ownership of the subsidiary company.

Acquisition Details

The board approved the acquisition of 2,000 equity shares of face value Rs. 100 each in Haris Marine Products Private Limited for a total consideration of Rs. 19,64,000. This transaction will be executed through acquisition from existing shareholders on a cash basis.

Shareholding Structure Change

Upon completion of this acquisition, Mukka Proteins Limited's shareholding in Haris Marine Products Private Limited will increase from the current 98% to 100%, making it a wholly owned subsidiary.

Target Company Profile

Haris Marine Products Private Limited operates in the same industry as its parent company, focusing on manufacturing and exporting fish meal and fish oil. The company was incorporated on October 30, 2019, and maintains its business presence in India.

Historical Performance

The subsidiary's revenue performance over the past three years shows:

• March 2023: Rs. 50,95,31,673
• March 2024: Nil
• March 2025: Nil

Strategic Rationale

The proposed investment forms part of Mukka Proteins Limited's strategic investment plans to expand its core business operations. Since both companies operate in the fish meal and fish oil manufacturing and export sector, this acquisition aligns with the parent company's business objectives and will strengthen its market position.

The transaction is classified as a related party transaction under the Companies Act, 2013, given the existing subsidiary relationship. The company has confirmed that the investment will be executed on an arm's length basis, with promoters having interest in Haris Marine Products Private Limited through their existing shareholding and directorship positions.

Mukka Proteins Limited announced that its Board of Directors has approved the acquisition of additional equity shares in subsidiary company Ento Proteins Private Limited (EPPL) during a meeting held on February 12, 2026. The strategic move will transform EPPL into a wholly owned subsidiary of the fish meal and fish oil manufacturer.

Acquisition Details

The Board approved the acquisition of 1,000 equity shares of face value Rs. 100 each in EPPL for a total consideration of Rs. 32,30,000. The shares will be acquired from existing shareholders through a cash transaction.

Shareholding Structure Changes

The acquisition will significantly alter Mukka Proteins' ownership structure in EPPL, increasing its control substantially.

Target Company Profile

Ento Proteins Private Limited operates in the alternative proteins sector, specializing in insect-based products. The company was incorporated on March 8, 2021, and has demonstrated consistent growth in its business operations.

Business Performance Trajectory

EPPL has shown steady revenue growth over the past three years in the insect meal and insect oil manufacturing segment:

Strategic Rationale

The acquisition forms part of Mukka Proteins' strategic investment plans to expand its alternate proteins business. EPPL's specialization in insect meal and insect oil manufacturing complements the parent company's existing portfolio in the protein sector. The transaction is being conducted on an arm's length basis, with EPPL classified as a related party due to its subsidiary status.

Regulatory Compliance

The Board meeting, which commenced at 4:00 p.m. and concluded at 4:45 p.m., was conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No governmental or regulatory approvals are required for completing this acquisition. The company has provided comprehensive disclosures as mandated under Schedule III of the Listing Regulations.